期刊
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
卷 21, 期 1, 页码 33-41出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.beem.2006.12.002
关键词
serotonin; 5-HIAA; carcinoid; insulinoma; gastrinoma; VIPoma; glucagonoma; somatostatinoma; chromogranins; neuron-specific enolase (NSE); alpha-subunits of the glycoprotein hormones; catecholamines; pancreatic polypeptide (PP); ghrelin; adrenomedullin
Several circulating or urinary tumour markers can be used for the diagnosis and follow-up of functioning and clinically non-functioning neuroendocrine tumours of the pancreatic islet cells and intestinal tract. Among the specific tumour markers are serotonin and its metabolites e.g. 5-hydroxyindoleacetic acid (5-HIAA) - in carcinoid tumours and the carcinoid syndrome, insulin and its precursors or breakdown products in insulinoma, and gastrin in gastrinoma. Plasma vasointestinal polypeptide (VIP) determinations have been used in the diagnosis of VIPoma, plasma glucagon for glucagonoma, and serum somatostatin for somatostatinoma. Among the tumour-non-specific markers are: chromogranins, neuron-specific enolase (NSE), alpha-subunits of the glycoprotein hormones, catecholamines, pancreatic polypeptide (PP), ghrelin and adrenomedullin.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据